活产
怀孕
辅助生殖技术
胚胎移植
产科
医学
繁殖
胎儿
妇科
不育
生物
生态学
遗传学
作者
Sonia Friedman,Pia Veldt Larsen,Jens Fedder,Bente Mertz Nørgård
出处
期刊:Gut
[BMJ]
日期:2016-04-21
卷期号:66 (3): 556.1-558
被引量:36
标识
DOI:10.1136/gutjnl-2016-311805
摘要
We recently reported that for women with UC receiving assisted reproductive technology (ART) treatment, the chance of a live birth after each embryo transfer cycle decreased significantly. In women with Crohn's disease (CD), the chance of a live birth after each embryo transfer cycle also decreased but was not significant in the fully adjusted regression model.1 In our study, we chose the outcome live birth because it was the most important clinical outcome for patients with UC and CD undergoing ART. After demonstrating the negative effects of UC and CD on chances of live birth, we wish to update our readers by exploring where along the process from fertilisation through pregnancy the risk of delivering a live born child decreases. Is the reduced chance of live birth due to (1) a reduced chance of conceiving after an ART cycle? and/or (2) a reduced chance of maintaining a fetus …
科研通智能强力驱动
Strongly Powered by AbleSci AI